EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery

Naina Sunildutt, Pratibha Parihar, Abdul Rahim Chethikkattuveli Salih, Sang Ho Lee, Kyung Hyun Choi

Frontiers in Pharmacology · 25.04.2023 · 14

DOI: 10.3389/fphar.2023.1139229 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.04.2023. Verfasst von Naina Sunildutt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inefficiency of existing animal models to precisely predict human pharmacological effects is the root reason for drug development failure. Microphysiological system/organ-on-a-chip technology (organ-on-a-chip platform) is a microfluidic device cultured with human living cells under specific organ shear stress which can faithfully replicate human organ-body level pathophysiology. This emerging organ-on-chip platform can be a remarkable alternative for animal models with a broad range of purposes in drug testing and precision medicine. Here, we review the parameters employed in using organ on chip platform as a plot mimic diseases, genetic disorders, drug toxicity effects in different organs, biomarker identification, and drug discoveries. Additionally, we address the current challenges of the organ-on-chip platform that should be overcome to be accepted by drug regulatory agencies and pharmaceutical industries. Moreover, we highlight the future direction of the organ-on-chip platform parameters for enhancing and accelerating drug discoveries and personalized medicine.

Schlagwörter

Stichwörter der Autor:innen

disease modellingdrug discoveryorgan on a chip (OCC)parameterspharmacokinetic & pharmacodynamic parameters

Autor:innen und Institutionen

  • Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea.
  • College of Pharmacy, Jeju National University, Jeju, Republic of Korea.

Förderung

  • National Research Foundation

Zitieren

APA

Sunildutt, N., Parihar, P., Chethikkattuveli Salih, A. R., Lee, S. H., & Choi, K. H. (2023). Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1139229

Vancouver

Sunildutt N, Parihar P, Chethikkattuveli Salih AR, Lee SH, Choi KH. Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1139229

BibTeX
@article{Sunildutt2023,
  author = {Sunildutt, Naina and Parihar, Pratibha and Chethikkattuveli Salih, Abdul Rahim and Lee, Sang Ho and Choi, Kyung Hyun},
  title = {Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1139229}
}
Kostenlos starten →